Agenus (AGEN) Short Interest Ratio & Short Volume $3.79 +0.13 (+3.55%) As of 02:19 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Agenus Short Interest DataAgenus (AGEN) has a short interest of 4.05 million shares, representing 19.65% of the float (the number of shares available for trading by the public). This marks a -1.94% decrease in short interest from the previous month. The short interest ratio (days to cover) is 7.3, indicating that it would take 7.3 days of the average trading volume of 593,191 shares to cover all short positions.Current Short Interest4,050,000 sharesPrevious Short Interest4,130,000 sharesChange Vs. Previous Month-1.94%Dollar Volume Sold Short$11.70 millionShort Interest Ratio7.3 Days to CoverLast Record DateApril 30, 2025Outstanding Shares27,417,000 sharesFloat Size20,610,000 sharesShort Percent of Float19.65%Today's Trading Volume481,112 sharesAverage Trading Volume593,191 sharesToday's Volume Vs. Average81% Short Selling Agenus? Sign up to receive the latest short interest report for Agenus and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartAGEN Short Interest Over TimeAGEN Days to Cover Over TimeAGEN Percentage of Float Shorted Over Time Agenus Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20254,050,000 shares $11.70 million -1.9%19.7%7.3 $2.89 4/15/20254,130,000 shares $6.98 million +9.6%16.8%7.9 $1.69 3/31/20253,770,000 shares $5.67 million +3.9%15.3%8.8 $1.51 3/15/20253,630,000 shares $6.75 million +12.4%14.7%8.3 $1.86 2/28/20253,230,000 shares $9.21 million +5.6%14.1%7.7 $2.85 2/15/20253,060,000 shares $10.74 million +4.4%13.4%6.7 $3.51 1/31/20252,930,000 shares $11.13 million -0.3%13.1%5.4 $3.80 1/15/20252,940,000 shares $9.32 million -0.3%13.2%5.7 $3.17 12/31/20242,950,000 shares $8.08 million +0.7%13.2%5.9 $2.74 12/15/20242,930,000 shares $8.94 million +6.6%13.1%5.9 $3.05 Get the Latest News and Ratings for AGEN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Agenus and its competitors with MarketBeat's FREE daily newsletter. 11/30/20242,750,000 shares $9.41 million +5.0%12.3%5.7 $3.42 11/15/20242,620,000 shares $7.13 million -6.4%11.8%5.8 $2.72 10/31/20242,800,000 shares $11.76 million -10.5%13.2%7.1 $4.20 10/15/20243,130,000 shares $14.59 million +10.6%14.7%7.4 $4.66 9/30/20242,830,000 shares $15.51 million -3.1%13.3%4.1 $5.48 9/15/20242,920,000 shares $18.28 million +4.3%14.2%4.1 $6.26 8/31/20242,800,000 shares $14.42 million +5.7%13.7%3.9 $5.15 8/15/20242,650,000 shares $13.70 million +21.6%12.9%3.3 $5.17 7/31/20242,180,000 shares $13.17 million -8.8%10.9%2.7 $6.04 7/15/20242,390,000 shares $37.28 million +1.3%12.0%2.5 $15.60 6/30/20242,360,000 shares $39.53 million +5.4%11.8%2.9 $16.75 6/15/20242,240,000 shares $34.63 million -18.0%11.2%2.8 $15.46 5/31/20242,730,000 shares $42.83 million -13.1%13.7%3.5 $15.69 5/15/20243,140,000 shares $33.85 million -3.1%15.7%4.3 $10.78 4/30/20243,240,000 shares $39.27 million +25.1%16.8%4.1 $12.12 4/15/20242,590,000 shares $16.84 million -94.6%13.0%3.9 $6.50 3/31/202447,720,000 shares $27.68 million +4.3%N/A4.5 $0.58 3/15/202445,750,000 shares $24.71 million +1.2%N/A4.4 $0.54 2/29/202445,190,000 shares $30.28 million +4.6%N/A3.8 $0.67 2/15/202443,200,000 shares $28.24 million -1.5%N/A3.6 $0.65 1/31/202443,850,000 shares $29.26 million +4.7%N/A4.1 $0.67 1/15/202441,880,000 shares $26.80 million +5.6%N/A4 $0.64 12/31/202339,660,000 shares $32.83 million -10.0%N/A4.1 $0.83 12/15/202344,080,000 shares $30.49 million +2.4%N/A5 $0.69 11/30/202343,070,000 shares $33.47 million -5.1%N/A6.3 $0.78 11/15/202345,370,000 shares $33.47 million +32.7%N/A8 $0.74 10/31/202334,180,000 shares $27.34 million +12.4%N/A6.6 $0.80 10/15/202330,410,000 shares $31.93 million +8.1%N/A7 $1.05 9/30/202328,130,000 shares $31.79 million -3.8%N/A7.3 $1.13 9/15/202329,250,000 shares $38.32 million -0.3%N/A7.1 $1.31A grave, grave error. (Ad)I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. Here’s the full story for you. 8/31/202329,350,000 shares $40.50 million +11.5%N/A5.9 $1.38 8/15/202326,320,000 shares $35.53 million +36.2%N/A5 $1.35 7/31/202319,330,000 shares $29.38 million +0.6%N/A3.8 $1.52 7/15/202319,210,000 shares $33.81 million -0.9%N/A3.7 $1.76 6/30/202319,390,000 shares $31.02 million -5.8%N/A3.5 $1.60 6/15/202320,590,000 shares $37.27 million +6.0%N/A3.7 $1.81 5/31/202319,430,000 shares $30.31 million -3.0%N/A3.6 $1.56 5/15/202320,030,000 shares $30.45 million +2.5%N/A3.8 $1.52 4/30/202319,550,000 shares $29.52 million -18.1%N/A3.8 $1.51 4/15/202323,880,000 shares $34.63 million -3.1%N/A4.7 $1.45 3/31/202324,640,000 shares $37.45 million +16.4%N/A5.2 $1.52 3/15/202321,170,000 shares $40.01 million +2.5%N/A4.5 $1.89 2/28/202320,650,000 shares $42.54 million +3.1%N/A5 $2.06 2/15/202320,030,000 shares $43.26 million -9.5%N/A5.1 $2.16 1/31/202322,140,000 shares $57.79 million +9.0%N/A5 $2.61 1/15/202320,320,000 shares $59.94 million +4.4%N/A4.6 $2.95 12/30/202219,460,000 shares $46.70 million +2.5%N/A4.5 $2.40 12/15/202218,990,000 shares $46.34 million -4.7%N/A4 $2.44 11/30/202219,930,000 shares $53.81 million -11.4%N/A4.2 $2.70 11/15/202222,500,000 shares $71.33 million +18.5%N/A4.7 $3.17 10/31/202218,990,000 shares $47.66 million +2.1%N/A4.3 $2.51 10/15/202218,600,000 shares $45.38 million +9.9%N/A4.1 $2.44 9/30/202216,920,000 shares $34.69 million +5.0%N/A3.7 $2.05 9/15/202216,120,000 shares $40.62 million -4.4%N/A3.3 $2.52 8/31/202216,860,000 shares $45.52 million -5.0%N/A3.3 $2.70 8/15/202217,740,000 shares $55.70 million +7.5%N/A3.5 $3.14 7/31/202216,510,000 shares $42.60 million +9.6%N/A3.2 $2.58 7/15/202215,070,000 shares $43.40 million -3.3%N/A3 $2.88 6/30/202215,590,000 shares $30.24 million +11.2%N/A3.2 $1.94 6/15/202214,020,000 shares $19.49 million -6.7%14.2%3.2 $1.39 5/31/202215,030,000 shares $25.10 million -10.9%N/A3.5 $1.67 5/15/202216,860,000 shares $27.48 million -19.5%N/A3.7 $1.63 4/30/202220,930,000 shares $38.72 million +1.2%N/A4.9 $1.85 4/15/202220,690,000 shares $48.41 million +3.4%N/A4.9 $2.34 3/31/202220,010,000 shares $49.22 million -23.0%N/A4.7 $2.46 3/15/202226,000,000 shares $69.16 million -18.4%N/A6.4 $2.66 2/28/202231,870,000 shares $86.05 million +14.7%N/A7.6 $2.70 2/15/202227,790,000 shares $71.14 million +5.1%N/A6.6 $2.56 1/31/202226,440,000 shares $72.97 million +4.1%N/A6.3 $2.76 1/15/202225,390,000 shares $77.44 million +3.1%N/A6 $3.05 12/31/202124,620,000 shares $79.28 million +31.9%N/A5.6 $3.22 12/15/202118,670,000 shares $61.80 million +8.1%N/A4.2 $3.31 11/30/202117,270,000 shares $54.40 million +13.2%7.8%4.2 $3.15 11/15/202115,260,000 shares $55.70 million -11.1%6.9%3.6 $3.65 10/29/202117,170,000 shares $65.93 million +14.2%8.6%4.1 $3.84 10/15/202115,040,000 shares $79.86 million -29.3%7.5%3.8 $5.31 9/30/202121,270,000 shares $111.67 million -0.4%10.6%6 $5.25 9/15/202121,360,000 shares $114.92 million -6.1%10.7%6.2 $5.38 8/31/202122,740,000 shares $140.31 million +1.6%11.4%6.6 $6.17 8/13/202122,380,000 shares $137.64 million -0.2%11.3%6.7 $6.15A grave, grave error. (Ad)I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. Here’s the full story for you. 7/30/202122,430,000 shares $116.19 million -0.7%11.9%4.6 $5.18 7/15/202122,580,000 shares $121.93 million -13.1%11.9%4.6 $5.40 6/30/202125,990,000 shares $142.69 million -6.3%13.7%5.1 $5.49 6/15/202127,740,000 shares $139.81 million -2.1%14.7%5.2 $5.04 5/28/202128,320,000 shares $120.64 million +3.7%15.0%5.4 $4.26 5/14/202127,310,000 shares $82.75 million -0.3%N/A5.3 $3.03 4/30/202127,380,000 shares $84.60 million -0.2%N/A8.1 $3.09 4/15/202127,430,000 shares $73.79 million +1.5%N/A6.9 $2.69 3/31/202127,020,000 shares $72.95 million +12.4%N/A7.4 $2.70 3/15/202124,040,000 shares $79.57 million -0.8%N/A7 $3.31 2/26/202124,230,000 shares $99.10 million +1.8%N/A8 $4.09 2/12/202123,810,000 shares $112.15 million -4.6%N/A8.4 $4.71 1/29/202124,950,000 shares $91.57 million 0.0%N/A9.1 $3.67 1/15/202124,960,000 shares $85.36 million +1.8%N/A11.4 $3.42 12/31/202024,530,000 shares $80.70 million +12.9%N/A12 $3.29 12/15/202021,720,000 shares $79.71 million -3.0%N/A10.9 $3.67 11/30/202022,390,000 shares $83.07 million -3.7%N/A8.7 $3.71 11/15/202023,240,000 shares $88.08 million -2.1%N/A9.5 $3.79 10/30/202023,730,000 shares $88.28 million +1.5%N/A9.5 $3.72 10/15/202023,380,000 shares $95.86 million +1.0%N/A8.8 $4.10 9/30/202023,150,000 shares $92.60 million +0.4%N/A8.3 $4.00 9/15/202023,050,000 shares $115.48 million -1.5%N/A7.8 $5.01 8/31/202023,400,000 shares $102.02 million -3.6%N/A8.5 $4.36 8/14/202024,280,000 shares $90.08 million +2.6%N/A7.8 $3.71 7/31/202023,660,000 shares $71.93 million +12.9%N/A7.4 $3.04 7/15/202020,950,000 shares $77.31 million +2.2%N/A6.7 $3.69 6/30/202020,510,000 shares $80.60 million +20.9%N/A6.6 $3.93 6/15/202016,960,000 shares $61.23 million -1.5%N/A5.5 $3.61 5/29/202017,210,000 shares $64.19 million +1.8%N/A5.3 $3.73 AGEN Short Interest - Frequently Asked Questions What is Agenus' current short interest? Short interest is the volume of Agenus shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 4,050,000 shares of AGEN short. 19.65% of Agenus' shares are currently sold short. Learn More on Agenus' current short interest. What is a good short interest ratio for Agenus? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. AGEN shares currently have a short interest ratio of 7.0. Learn More on Agenus's short interest ratio. Which institutional investors are shorting Agenus? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Agenus: Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Agenus? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 19.65% of Agenus' floating shares are currently sold short. Is Agenus' short interest increasing or decreasing? Agenus saw a decline in short interest in April. As of April 30th, there was short interest totaling 4,050,000 shares, a decline of 1.9% from the previous total of 4,130,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Agenus' float size? Agenus currently has issued a total of 27,417,000 shares. Some of Agenus' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Agenus currently has a public float of 20,610,000 shares. How does Agenus' short interest compare to its competitors? 19.65% of Agenus' shares are currently sold short. Here is how the short interest of companies in the industry of "biotechnology" compare to Agenus: XOMA Co. (1.66%), Lexicon Pharmaceuticals, Inc. (10.31%), Vanda Pharmaceuticals Inc. (8.48%), Codexis, Inc. (6.87%), Sangamo Therapeutics, Inc. (12.12%), Ironwood Pharmaceuticals, Inc. (5.62%), Achieve Life Sciences, Inc. (7.29%), Dominari Holdings Inc. (6.10%), Fortress Biotech, Inc. (17.46%), Curis, Inc. (1.48%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Spotify Technology S.A. ($4.67 billion), Charter Communications, Inc. ($4.58 billion), Capital One Financial Co. ($4.47 billion), The Kroger Co. ($2.56 billion), Reddit, Inc. ($2.23 billion), Rivian Automotive, Inc. ($2.16 billion), Live Nation Entertainment, Inc. ($1.90 billion), SoFi Technologies, Inc. ($1.85 billion), Zscaler, Inc. ($1.75 billion), and Omnicom Group Inc. ($1.75 billion). View all of the most shorted stocks. What does it mean to sell short Agenus stock? Short selling AGEN is an investing strategy that aims to generate trading profit from Agenus as its price is falling. AGEN shares are trading down $0.18 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Agenus? A short squeeze for Agenus occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of AGEN, which in turn drives the price of the stock up even further. How often is Agenus' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including AGEN, twice per month. The most recent reporting period available is April, 30 2025. More Short Interest Resources from MarketBeat Related Companies XOMA Short Interest Lexicon Pharmaceuticals Short Interest Vanda Pharmaceuticals Short Interest Codexis Short Interest Sangamo Therapeutics Short Interest Ironwood Pharmaceuticals Short Interest Achieve Life Sciences Short Interest Dominari Short Interest Fortress Biotech Short Interest Curis Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:AGEN) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredWatch This Robotics Demo Before July 23rdJeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... ...Brownstone Research | SponsoredThe Prophet's Newest PredictionA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...Stansberry Research | SponsoredThe Collapse Has Already Started — Your 401(k) Is NextThere's a major heist happening on American wealth in real time. Except this one doesn't involve masks or v...American Hartford Gold | SponsoredElon’s 2025 Silver Crisis (What It Means for You)Elon Musk is back in the spotlight—this time for fueling a global scramble for silver. Tesla's relentless p...GoldenCrest Metals | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredTrump’s Bitcoin Reserve is No Accident…How everyday investors are building crypto wealth (step-by-step guide) Don't wait. The window for maximum g...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Agenus Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Agenus With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
